Wegovy pill 25mg: maintenance dose guide UK

Quick answer: 25mg is the target maintenance dose for most people on the Wegovy pill, reached after roughly 13 weeks of gradual dose increases through 1.5mg, 4mg and 9mg. It is the dose associated with the greatest average weight loss in clinical trials, and most people who reach it continue taking it for as long as it remains effective and well tolerated, reviewed periodically with their prescriber. This guide covers what to expect once you are here, not just how you got here.

Availability note: 25mg is not treated as generally available in the UK until 20 July 2026. Before then, use this page as a maintenance-dose explainer rather than a live buying signal.

How long it takes to reach 25mg

Following the standard titration schedule, 25mg is typically reached around day 91, roughly the start of month 4, after 30 days each at 1.5mg, 4mg and 9mg. Some people stay longer at an earlier stage if their prescriber decides that is the right call for tolerability. Reaching 25mg on a slower schedule does not mean anything has gone wrong.

What the trial data showed

In Novo Nordisk’s OASIS 4 trial, a 64-week, randomised, placebo-controlled phase III study of 307 adults taking once-daily oral semaglutide 25mg, participants achieved an average 16.6% body weight reduction with full adherence to treatment, compared with 2.7% on placebo. In the wider treatment-policy analysis, which includes people who did not fully adhere, the average was 13.6% versus 2.2% on placebo. These are trial-population averages from a controlled study, not a personal prediction. Individual results vary.

Sources: American College of Cardiology summary and Applied Clinical Trials Online. Confirm against the latest published trial data or SmPC if the source record changes.

The 6-month continuation review

A common pattern for GLP-1 weight-management medicines in UK clinical practice is a structured review around 6 months on treatment, checking whether you have lost a clinically meaningful amount of weight and whether side effects remain manageable. If you have, many prescribers will support continuing for as long as treatment remains beneficial. If progress has stalled and side effects are a problem, your prescriber may discuss alternatives. This is general information about how these reviews commonly work, not a fixed rule for every provider.

Long-term side-effect management differs from the titration phase

By the time you are stable on 25mg, most of the adjustment-phase nausea and stomach upset common in the first few months has usually settled. Long-term attention shifts more toward nutrition, eating enough protein and fibre despite reduced appetite, hydration, and staying alert to any new or unusual symptoms, including the rare NAION eye-condition signal covered in our latest Wegovy pill updates. That is not a reason for alarm, but it is worth understanding at any stage of treatment.

What staying on 25mg costs over time

Because 25mg is usually the most expensive dose stage, cost adds up the longest at this stage of any in the schedule. Check live 25mg pricing from providers with a confirmed maintenance-dose row on CompareWegovyPrices, and do not assume a starter-dose price carries through to the maintenance dose.

Use our true-cost journey calculator to estimate a full treatment journey that includes the maintenance stage.

Switching providers while on 25mg

If you are already stable on 25mg and considering switching providers for price or service reasons, make that decision with your prescriber, not purely on cost. Continuity of care, consultation history and how a new provider handles an existing prescription all matter.

Related guides

• 1.5mg dose stage guide
• 4mg dose stage guide
• 9mg dose stage guide
• 25mg dose stage guide

This guide is general information, not medical advice. Always follow your own prescriber’s guidance on dose duration, review timing and any decision to continue, change or stop treatment.